BIOLASE Inc. Director Federico Pignatelli Initiates Process To Obtain Books And Records To Investigate Suspected Wrongdoing, Mismanagement And Corporate Governance Failures

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LOS ANGELES--(BUSINESS WIRE)--Federico Pignatelli, former CEO and current director and stockholder of Biolase, Inc. (Nasdaq:BIOL), has initiated a process pursuant to Section 220(b) and (d) of the Delaware General Corporation Law to obtain certain books and records from Biolase management relating to suspected wrongdoing, mismanagement and corporate governance failures by the company’s board of directors.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC